Boehringer Sees Opportunities For Jascayd In Evolving China IPF Landscape

Reimbursement The Next Step

 
• By Xu Hu
  
Healthy lungs
BI looks to reimbursement as next step for recently approved IPF drug in China (Shutterstock)

More from Interviews

More from China